[ Price : $8.95]
FDA commissioner Robert Califf says the agency has launched a drug overdose prevention framework with four overarching priorities.[ Price : $8.95]
FDA lifts a partial clinical hold on Curis TakeAim Leukemia study that is intended to evaluate emavusertib in a monotherapy phase ...[ Price : $8.95]
Hamilton Medical recalls its Hamilton-C6 Intensive Care Ventilator after customer complaints were received about a hardware issue ...[ Price : $8.95]
Outlook Therapeutics resubmits to FDA a BLA for its ONS-5010 to treat wet age-related macular degeneration.[ Price : $8.95]
Erytech Pharma says it is no longer planning to submit a BLA for Graspa in hypersensitive acute lymphoblastic leukemia following F...[ Price : $8.95]
New Phase 3 data on AstraZeneca's Farxiga (dapagliflozin) demonstrate a mortality benefit compared to placebo in patients with hea...[ Price : $8.95]
Intera Oncology recalls its Intera 3000 Hepatic Artery Infusion Pump due to complaints the device was delivering medications faste...[ Price : $8.95]
Federal Register notice: FDA posts two draft guidances entitled Q2(R2) Validation of Analytical Procedures and Q14 Analytical Proc...